Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7447
Rank
$0.54 B
Marketcap
$15.66
Share price
0.26%
Change (1 day)
-50.17%
Change (1 year)

Avalon Pharma (Middle East Pharmaceutical) (4016.SR) - Total assets

Total assets on the balance sheet as of March 2026 : $0.16 Billion USD

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's total assets are $0.16 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Avalon Pharma (Middle East Pharmaceutical) - Total assets on balance sheet (from 2023 to 2026)

Total assets by year

Year Total assets Change
2025-12-31$0.15 B13.93%
2024-12-31$0.14 B16.15%
2023-12-31$0.12 B